Company Overview and News

 
InterGlobe Aviation Limited - Credit Rating

2018-10-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
INDIGO 539448

 
IndiGo, SpiceJet, Jet Airways share price zooms up to 10.5%; two key reasons why

2018-10-16 financialexpress
Aviation stocks rallied on Tuesday, with share prices of IndiGo, SpiceJet, Jet Airways zooming up to 11% intraday on the back of a rising rupee and falling global crude oil prices. Notably, shares of Interglobe Aviation, which runs the IndiGo airline rose by more than 7% to hit an intra-day high of Rs 875.85 on BSE this afternoon. Spicejet shares rallied by more than 6% to hit day’s high of Rs 74.40.
INDIGO 532617 JETAIRWAYS 539448

 
SpiceJet, InterGlobe Aviation, Jet Airways gain 3-7% on fall in crude oil price

2018-10-16 moneycontrol
Share of aviation stock companies rose 3-7 percent intraday Tuesday on the back of falling crude oil prices.
INDIGO 532617 JETAIRWAYS 539448

 
IndiGo to start flights to Male from Bengaluru, Mumbai and Kochi

2018-10-16 livemint
New Delhi: IndiGo is expanding its overseas network with the launch of flight services to Male and Phuket from next month. IndiGo is introducing non-stop flights between Male’ and Kochi, Bengaluru and Mumbai, with effect from 15 November 2018, the carrier mentioned on its website. Male will be connected to Mumbai, Bengaluru and Kochi, while services to Phuket will be operated from Delhi, IndiGo said.
INDIGO 539448

 
IndiGo eyes wide-bodied aircraft from Airbus, Boeing: Willy Boulter

2018-10-14 thehindubusinessline
Indian airline IndiGo on Sunday said wide-bodied aircraft are an aspiration and talks with manufacturers are ongoing but there is no firm timeline amid difficult market conditions in the Indian market.
INDIGO 539448

 
India's IndiGo eyes wide-bodied aircraft from Airbus, Boeing: executive

2018-10-14 channelnewsasia
Indian airline IndiGo on Sunday said wide-bodied aircraft are an “aspiration” and talks with manufacturers are ongoing but there is no firm timeline amid difficult market conditions in the Indian market.
INDIGO 539448

 
India's IndiGo eyes wide-bodied aircraft from Airbus, Boeing: executive

2018-10-14 reuters
ABU DHABI (Reuters) - Indian airline IndiGo on Sunday said wide-bodied aircraft are an “aspiration” and talks with manufacturers are ongoing but there is no firm timeline amid difficult market conditions in the Indian market.
INDIGO 539448

 
Excise duty on jet fuel drives airline stocks up 6%

2018-10-12 thehindubusinessline
Airline stocks continued to gain for the third consecutive session on Friday, gaining up to 6 per cent, due to excise duty cut on jet fuel and easing crude prices. Shares of InterGlobe Aviation zoomed 6.03 per cent, Jet Airways rose 4.89 per cent and SpiceJet gained 3.63 per cent on the BSE.
INDIGO UBL 532617 UBHOLDINGS JETAIRWAYS 507458 UNBWY 539448 532478

 
Airline stocks shoot up 3 percent

2018-10-12 freepressjournal.in
NEW DELHI: Airline stocks bucked the weak broader market sentiment and ended with up to 3 per cent gains Thursday after the government cut excise duty on jet fuel to 11 per cent to give relief to the aviation industry. Shares of InterGlobe Aviation gained 3.25 per cent, SpiceJet rose 3.16 per cent and Jet Airways 1.11 per cent on the BSE. In intra-day trade, these stocks surged up to 7.44 per cent.
INDIGO 532617 JETAIRWAYS 539448

 
Aviation stocks soar: Spicejet, Jet Airways, IndiGo share prices zoom up to 11% after ATF excise cut

2018-10-11 financialexpress
Aviation stocks got a fillip on Thursday morning, with shares of Spicejet, Jet Airways, IndiGo gaining as much as 8% in the morning trade, after the government announced excise duty cut on turbine fuel yesterday. The Narendra Modi government announced excise duty cut on Aviation Turbine Fuel (ATF) from 14% to 11%, providing relief to the aviation industry from higher fuel prices. Reacting to the news aviation stocks surged, with Interglobe Aviation shares zooming more than 10.
INDIGO 532617 JETAIRWAYS 539448

 
Aviation stocks rise after cut in jet fuel tax

2018-10-11 thehindubusinessline
Shares of Indian airlines bucked the weak trend in the overall market and posted gains on Thursday after the Government had agreed to cut the factory gate tax on jet fuel to 11 per cent from 14 per cent
INDIGO 532617 BHARATGEAR JETAIRWAYS 505688 539448

 
Aviation stocks rises 7% on excise cut on ATF, lower crude prices

2018-10-11 moneycontrol
Aviation stocks SpiceJet, Interglobe Aviation and and Jet Airways are trading higher by 4-7 percent on Thursday after government cut the excise on ATF prices.
INDIGO 532617 JETAIRWAYS 539448

 
Aviation stocks down 5% despite excise cut on ATF

2018-10-11 moneycontrol
Aviation stocks SpiceJet, Interglobe Aviation and and Jet Airways are trading lower with a cut of 4-5 percent on Thursday despite government cut the excise on ATF prices.
INDIGO 532617 JETAIRWAYS 539448

5
Markets stage relief rally; banking, auto stocks lead

2018-10-10 freepressjournal.in
Mumbai: Benchmark indices staged a strong comeback Wednesday after the recent rout as investors accumulated battered financials, auto and metal stocks amid rupee recovery from record lows. The BSE Sensex, after a gap up opening of 34,493.21, rallied to hit a high of 34,858.35 before ending 461.42 points, or 1.35 per cent, higher at 34,760.89. The broader Nifty too reclaimed the key 10,400 mark. It touched a high of 10,482.
BAJAJ-AUTO 500820 BNPQY 532978 532977 SRTRANSFIN BHRQY ASIANPAINT 533278 532215 511218 500470 532187 AXISBANK SRRQY HDFCBANK HEROMOTOCO 500570 BHARTIARTL TATAMOTORS CLNDY YESBANK INDIGO AXB INDUSINDBK IBN 532648 YYBKY BNPQF 539448 AXBKY 532454 500182 BNPZY AXBA ICICIBANK BAJAJFINSV TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA TTM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...